Valuation (2%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -24.07 | -17.50 |
PEG Ratio (TTM) | -0.41 | -5.54 |
P/S Ratio (TTM) | N/A | 39.12 |
P/B Ratio (TTM) | 10.61 | 5.81 |
P/FCF Ratio (TTM) | -22.47 | -146.29 |
Price to 5YR AVG Earnings Ratio | N/A | -33.98 |
Price to 5YR AVG FCF Ratio | N/A | -1.00 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -12.43% | 288.38% |
ROE (TTM) | -16.23% | -4,234.58% |
Net Profit Margin (TTM) | N/A | -1,039.68% |
ROIC 5YR AVG | N/A | -15.85% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 171.62% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -2,651.76% | N/A | N/A |
Cash Flow | -336.24% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.00 | 4.94 |
Quick Ratio (TTM) | 0.00 | 4.92 |
D/E Ratio (TTM) | 0.85 | 1.30 |
Interest Coverage (TTM) | -2.73 | -11.12 |
Piotroski F-Score | 1 | 3 |
Altman Z-Score | 0.79 | 20.99 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 891.89% |